Study Identifies Gene for Ovarian Cancer

Published Online: Tuesday, November 1, 2005

An excess of the Rsf-1 gene may play an important role in the development of ovarian cancer, based on an analysis of tissue from 7 ovarian cancer samples. Using a digital karyotyping technique to identify "subchromosomal alterations," the researchers observed an overproduction of the Rsf-1 gene located on chromosome 11 in 13.2% of the most aggressive forms of ovarian cancer. These results were not seen in any of the low-grade ovarian cancers.

Because this was the first study to identify this genetic alteration, the new finding may lead to the development of a drug to block the activity of Rsf-1 and therefore stop the cancerous cell growth, concluded senior researcher Tian-Li Wang, PhD, in the Proceedings of the National Academy of Sciences (September 27, 2005).

Latest Articles
Skipping a flu shot may put patients at greater risk for flu-related pneumonia.
This weekly video program highlights the latest in pharmacy news, product news, and more.
Mylan has launched a generic version of Teva Pharmaceuticals’ Adderall in 5 mg, 7.5 mg, 10 mg, 12.5 mg, 20 mg, and 30 mg doses.
The FDA has approved Boehringer Ingelheim’s oral direct thrombin inhibitor dabigatran etexilate mesylate (Pradaxa) for the prophylaxis of deep vein thrombosis and pulmonary embolism in patients who have had hip replacement surgery.
Latest Issues